Register
Login:
Share:
Email Facebook Twitter

PIM Share Chat - RSS Feed

Plant Impact Share Chat (PIM)



Share Price: 34.50Bid: 34.00Ask: 35.00Change: 0.00 (0.00%)No Movement on Plant Impact
Spread: 1.00Spread as %: 2.94%Open: 34.50High: 34.50Low: 34.50Yesterday’s Close: 34.50


Share Discussion for Plant Impact (PIM)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


hereandnow
Posts: 359
Answer
Opinion:Strong Buy
Price:37.25
View Thread (2)
RE: h
20 Nov '14
Thanks. A lesson in patience and back your winners and sell your losers
 
shan
Posts: 4,689
Observation
Opinion:No Opinion
Price:37.25
pim trading update.
20 Nov '14
Just keeps going!
riddler
Posts: 67,540
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:36.50
View Thread (2)
h
20 Nov '14
nice one guys
hereandnow
Posts: 359
Observation
Opinion:Strong Buy
Price:36.00
Trading update
20 Nov '14
Great news today. Sales more than doubled and broken even. The future looks very positive
hereandnow
Posts: 359
Observation
Opinion:Strong Buy
Price:33.50
two good write ups
8 Nov '14
one in shares magazine, which is behind a pay wall and one from iii, link below

http://www.iii.co.uk/articles/203934/harvesting-profits-agribusiness
shan
Posts: 4,689
Observation
Opinion:No Opinion
Price:34.13
pim
4 Nov '14
Seems next leg up...excellent rise thus far.
hereandnow
Posts: 359
Answer
Opinion:Strong Buy
Price:31.00
View Thread (2)
RE: Excellent Rns...
27 Oct '14
Great results and an excellent overview of what the company is about
EarlyBird-Rns
Posts: 1,989
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:29.00
View Thread (2)
Excellent Rns...
27 Oct '14
.................
hereandnow
Posts: 359
Observation
Opinion:Strong Buy
Price:28.25
interesting
22 Oct '14
http://www.dailymail.co.uk/money/markets/article-2803912/MARKET-REPORT-Growing-returns-Plant-Health-Care-buyers-pile-in.html

Anyone familiar with our Chairman and CEO's back stories?

Dr David Jones, Non-Executive Chairman

An agribusiness professional with over 30 years of industry experience, David brings expertise in corporate strategy and vision to the board of PI. Formerly Chairman of Arysta Life Science, David was head of Business Development for Syngenta between 2000 and 2007, after leading the merger and integration between Zeneca Agrochemicals and Novartis. Prior to that he spent 10 years with Zeneca Agrochemicals, first as Regional Manager for Asia, Africa and Australia and latterly as Strategy and Product Director.

John Brubaker, CEO

Formerly global head of business development at Arysta LifeScience, John has demonstrated his track record of performance as a corporate development and sales and marketing leader in both multinational and growth-phase businesses. John has led initiatives and investments in developed and emerging markets, with particular experience of acquisition strategy and direction.
As director of business development at R4 Global Solutions, a technology-sector leader, he managed all aspects of the company’s business transition and was responsible for the sales partnership and business programme.
hereandnow
Posts: 359
Answer
Opinion:Strong Buy
Price:33.75
View Thread (2)
RE: Guys
5 Oct '14
none of the ones you mentioned. their major partner is Bayer in Brazil with a product called veritas for soya……..you should read the past couple of years RNSs. should see some very good sales growth this winter.

i hope to see a similar partnership start for soya in Argentina and hopefully one for the USA. some initial pilot projects and then roll out. lots of growth potential and this is just one product





Sign up for Live Prices


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.